Selected Start-Ups (11/00)
In Vivo summarizes the technologies of several recently founded companies: CryoCor Inc.will use cryonic ablation technology to treat cardiac arrhythmias. Expert Biomed Inc.is engaged in the search for therapeutics for Alzheimer's disease as well as new cancer diagnostics. Hypnion Inc. will use specialized screening and functional genomics services to discover novel drugs for sleep disorders and circadian rhythm abnormalities. France's Nautilus Biotech will use its proprietary analytical and gene transfer vector technology to support the drug discovery efforts of its customers. Neurogenetics Inc. aims to develop small molecule therapeutics to halt the progression of Alzheimer's disease and other neurodegenerative disorders. Robinson Medical Inc. will commercialize technology for the non-invasive continuous, real-time measurement of blood flow during cardiac surgery.
You may also be interested in...
Manufacturers Should Map Processes, Bolster Quality Culture To Tackle Data Integrity Problems in The Microbiology Lab
To reduce the opportunity for data integrity failures in the microbiology lab, manufacturers should map out the workflow so that activities and expectations for employees are clearly spelled out. Having formalized processes will ensure that employees don’t cut corners.
Companies can have their EU centralized marketing authorization application and submission for an Article 58 opinion (on medicines for use in non-EU countries) reviewed in parallel by the European Medicines Agency. The simultaneous assessment can be helpful when drugs and vaccines are needed for both EU and non-EU populations.
The coronavirus could have serious adverse effects on regulatory procedures at both European Medicines Agency and EU member state level. A new business continuity plan describes how procedures will be prioritized if problems arise.